Skip to main content scroll back to top of page

Utility Navigation

Careers

Primary Navigation

Close Menu

Pipeline
- Our Pipeline
  Our PipelineOur Pipeline
  Imipridones Tembexa®
  Oncology
  
  ONC201 for gliomas
  
  ONC206 for central nervous system tumors
  
  ONC212 IND-enabling studies
  
  Biodefense
  
  TEMBEXA^® for smallpox
  
  Publications Presentations SNO Conference
Company
Patients
- Expanded Access
- Clinical Trials
Products
- TEMBEXA®
Investors
Contact

« All Publications

imipridones

Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality

Cancer Cell 2019 PMID: 31056398

View Publication

Chimerix on LinkedIn
Chimerix on Twitter

Legal Menu

Privacy Policy
Terms & Conditions of Use
Forward-Looking Statements
Community Guidelines
References

© 2022 Copyright Chimerix. All rights reserved.